title: [Calcium channel blockers in ischemic cardiopathies].
abstract: Calcium-entry blockers are the drugs of choice in coronary spasm, unstable angina, and when patients do not have any effort limitation. However, beta-blockers, without sympathomimetic activity, remain the treatment of angina pectoris. When clinical situation is difficult to control, association calcium blockers and bêta-blockers are more efficient than monotherapy. In myocardial infarction, results are controversial: calcium channel blockers should be administered only with beta-blockers.
authors.forename: A
authors.initials: A
authors.lastname: Serradimigni
authors.forename: R
authors.initials: R
authors.lastname: Jouve
authors.forename: J M
authors.initials: JM
authors.lastname: Gilgenkrantz
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D003329:Coronary Vasospasm / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy
chemical_list: D002121:Calcium Channel Blockers
vernacular_title: Les inhibiteurs du canal calcique lent dans les cardiopathies ischémiques.